12月9日,BIONNOVA生物医药创新者论坛在上海正式拉开帷幕。本次论坛以“创新、合作、重新想象”为主题,秉承赋能生物医药产业创新发展的使命,齐聚行业大咖及专家,参会人数约700人。 圆桌讨论,主题演讲精彩纷呈 9日下午,Bio-Techne中国区总经理裴立文先生 ...
2019年1月, Bio-Techne 正式发布了细胞和基因治疗全产品线方案。作为业内重要的GMP级原辅试剂和仪器供应商,Bio-Techne的解决方案可渗透入细胞和基因治疗的各个阶段:从早期的科研发现、细胞治疗生产工艺优化到最终的工业生产。 Bio-Techne秉持博采众方的精神 ...
2019年12月18日,北京昭衍新药研究中心股份有限公司(后简称“昭衍新药”)与Bio-Techne在北京亦庄举行了战略合作签约仪式暨昭衍新药-安迪生物联合技术平台揭牌仪式。双方领导出席此次签字仪式,出席的有 Bio-Techne 大中华区董事总经理裴立文、昭衍新药总经理 ...
Bio-Techne公司近日宣布以RNAscope平台为基础,推出可检测小分子RNA的miRNAscope™ Assay。RNAscope技术是一种先进的RNA荧光原位杂交检测,能够显示单分子RNA在完整组织中的位置,且具有单细胞分辨率。 Bio-Techne公司近日宣布以RNAscope平台为基础,推出可检测小分子RNA的 ...
Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual ...
3.沙浴流化床采用三氧化二铝作为温度传输介质(主机标配已包含),干粉状,无毒、无腐蚀、不易燃,无棱角不会磨损样品表面,不会与样品反应产生有毒气体,不会像水浴产生表面张力、不会浸湿样品、绝缘性不会导电,通过真空泵对热空气循环,比油浴更 ...
Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present ...
Bio-Techne's shares have been pressured lately on concerns about the academic research market and biopharma R&D restructuring, but core business trends look largely intact. Fiscal Q2 showed revenue ...
Techne Corporation, the Minneapolis-based biotechnology company that now does business under the “Bio-Techne” brand, recently announced that it’s investing $10 million CyVek, Inc.—and it might ...
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their ...
Bio-Techne TECH reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of 53 cents, which surpassed the Zacks Consensus Estimate by 6%. The bottom line improved from the year-ago figure ...
BERLIN (dpa-AFX) - Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi Biotec B.V. & Co. KG, which may appeal the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果